Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 189239, 9 pages
http://dx.doi.org/10.1155/2015/189239
Research Article

Echinacoside Protects against 6-Hydroxydopamine-Induced Mitochondrial Dysfunction and Inflammatory Responses in PC12 Cells via Reducing ROS Production

1Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
3Shenyang Pharmaceutical University, Shenyang 110016, China

Received 12 September 2014; Revised 11 January 2015; Accepted 16 January 2015

Academic Editor: Paul Siu-Po Ip

Copyright © 2015 Yue-Hua Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Noelker, M. Bacher, P. Gocke et al., “The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity,” Neuroscience Letters, vol. 383, no. 1-2, pp. 39–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Blum, S. Torch, N. Lambeng et al., “Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease,” Progress in Neurobiology, vol. 65, no. 2, pp. 135–172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Swerdlow, “The neurodegenerative mitochondriopathies,” Journal of Alzheimer's Disease, vol. 17, no. 4, pp. 737–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Karbowski, “Mitochondria on guard: role of mitochondrial fusion and fission in the regulation of apoptosis,” Advances in Experimental Medicine and Biology, vol. 687, pp. 131–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. T. Shih, I. J. Chen, Y. C. Wu, and Y. C. Lo, “San-Huang-Xie-Xin-Tang protects against activated microglia- and 6-OHDA-induced toxicity in neuronal SH-SY5Y cells,” Evidence Based Complementory and Alternative Medicine, vol. 2011, Article ID 429384, 11 pages, 2011. View at Publisher · View at Google Scholar
  6. B. S. Jeon, V. Jackson-Lewis, and R. E. Burke, “6-Hydroxydopamine lesion of the rat Substantia nigra: time course and morphology of cell death,” Neurodegeneration, vol. 4, no. 2, pp. 131–137, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Nie, Y. Cao, and B. Zhao, “Protective effects of green tea polyphenols and their major component, (−)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells,” Redox Report, vol. 7, no. 3, pp. 171–177, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Nie, C. Jin, Y. Cao, S. Shen, and B. Zhao, “Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells,” Archives of Biochemistry and Biophysics, vol. 397, no. 1, pp. 84–90, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-H. Wang, H.-T. Yu, X.-P. Pu, and G.-H. Du, “Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression,” Molecules, vol. 18, no. 12, pp. 14726–14738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-H. Wang, Z.-H. Xuan, S. Tian, G.-R. He, and G.-H. Du, “Myricitrin attenuates 6-hydroxydopamine-induced mitochondrial damage and apoptosis in PC12 cells via inhibition of mitochondrial oxidation,” Journal of Functional Foods, vol. 5, no. 1, pp. 337–345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Fornstedt, E. Rosengren, and A. Carlsson, “Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species,” Neuropharmacology, vol. 25, no. 4, pp. 451–454, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Lei, F. Q. Yang, T. Y. Zhang, P. Tu, L. Wu, and Y. Ito, “Preparative isolation and purification of acteoside and 2′-acetyl acteoside from Cistanches salsa (C.A. Mey.) G. Beck by high-speed counter-current chromatography,” Journal of Chromatography A, vol. 912, no. 1, pp. 181–185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. W. He, T. Fang, and P. Tu, “Research progress on pharmacological activities of echinacoside,” Zhongguo Zhong Yao Za Zhi, vol. 34, no. 4, pp. 476–479, 2009. View at Google Scholar · View at Scopus
  14. Y. Li, Y.-Y. Song, and H.-Q. Zhang, “Effect of echinacoside on immune function and mitochondrial DNA relative content of aging mice,” Chinese Pharmacological Bulletin, vol. 26, no. 6, pp. 810–813, 2010. View at Google Scholar · View at Scopus
  15. G. Muteliefu, L. Li, and P. F. Tu, “Study on molecular mechanism of echinacoside for against aging,” Acta Biophysica Sinica, vol. 20, no. 3, pp. 184–187, 2004. View at Google Scholar
  16. X. Geng, X. Tian, P. Tu, and X. Pu, “Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease,” European Journal of Pharmacology, vol. 564, no. 1–3, pp. 66–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Chen, F. C. Jing, C. L. Li, P. F. Tu, Q. S. Zheng, and Z. H. Wang, “Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion rats,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 285–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Deng, J. Y. Zhao, P. F. Tu, Y. Jiang, Z. B. Li, and Y. H. Wang, “Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis,” European Journal of Pharmacology, vol. 505, no. 1–3, pp. 11–18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y.-H. Wang and G.-H. Du, “Ginsenoside Rg1 inhibits β-secretase activity in vitro and protects against Aβ-induced cytotoxicity in PC12 cells,” Journal of Asian Natural Products Research, vol. 11, no. 7, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Tirmenstein, C. X. Hu, M. S. Scicchitano et al., “Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells,” Toxicology in Vitro, vol. 19, no. 4, pp. 471–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-H. Wang, H.-T. Yu, Y.-P. Han, X.-P. Pu, and G.-H. Du, “Protocatechualdehyde prevents methylglyoxal-induced mitochondrial dysfunction and AGEs-RAGE axis activation in human lens epithelial cells,” European Journal of Pharmacology, vol. 738, no. 6, pp. 374–383, 2014. View at Publisher · View at Google Scholar
  22. Y.-H. Wang, H.-T. Yu, X.-P. Pu, and G.-H. Du, “Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-κB pathway activation in SH-SY5Y cells,” Journal of Molecular Neuroscience, vol. 53, no. 4, pp. 562–570, 2014. View at Publisher · View at Google Scholar
  23. R. A. Eliseev, J. Malecki, T. Lester, Y. Zhang, J. Humphrey, and T. E. Gunter, “Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect,” The Journal of Biological Chemistry, vol. 284, no. 15, pp. 9692–9699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Hermann, A. M. Zeiher, and S. Dimmeler, “Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 12, pp. 3588–3592, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. D.-S. Hwang, H. G. Kim, H.-J. Kwon et al., “Dangguijakyak-san, a medicinal herbal formula, protects dopaminergic neurons from 6-hydroxydopamine-induced neurotoxicity,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 934–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. H. V. Schapira, “Mitochondrial dysfunction in neurodegenerative disorders,” Biochimica et Biophysica Acta: Bioenergetics, vol. 1366, no. 1-2, pp. 225–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Beal, “Parkinson's disease: a model dilemma,” Nature, vol. 466, no. 7310, pp. S8–S10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Ferger, C. Themann, S. Rose, B. Halliwell, and P. Jenner, “6-Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation,” Journal of Neurochemistry, vol. 78, no. 3, pp. 509–514, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Méndez-Álvarez, R. Soto-Otero, Á. Hermida-Ameijeiras, M. E. López-Martín, and J. L. Labandeira-García, “Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants,” Free Radical Biology and Medicine, vol. 31, no. 8, pp. 986–998, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Ma, X. Wei, C. Fontanilla et al., “Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity,” Life Sciences, vol. 79, no. 13, pp. 1307–1311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Bensadoun, O. Mirochnitchenko, M. Inouye, P. Aebischer, and A. D. Zurn, “Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice,” European Journal of Neuroscience, vol. 10, no. 10, pp. 3231–3236, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Ferger, P. Teismann, and J. Mierau, “The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study,” Brain Research, vol. 883, no. 2, pp. 216–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Prokai-Tatrai and L. Prokai, “Impact of metabolism on the safety of estrogen therapy,” Annals of the New York Academy of Sciences, vol. 1052, no. 6, pp. 243–257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Sas, H. Robotka, J. Toldi, and L. Vécsei, “Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders,” Journal of the Neurological Sciences, vol. 257, no. 1-2, pp. 221–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Nakai, A. Mori, A. Watanabe, and Y. Mitsumoto, “1-Methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Δψm) in rat striatum,” Experimental Neurology, vol. 179, no. 1, pp. 103–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Saito, K. Nishio, Y. Ogawa et al., “Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action,” Free Radical Biology and Medicine, vol. 42, no. 5, pp. 675–685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Przedborski, “Inflammation and Parkinson's disease pathogenesis.,” Movement Disorders, vol. 25, supplement 1, pp. S55–S57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Barcia, A. F. Barreiro, M. Poza, and M.-T. Herrero, “Parkinson's disease and inflammatory changes,” Neurotoxicity Research, vol. 5, no. 6, pp. 411–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Mogi, M. Harada, T. Kondo et al., “Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients,” Neuroscience Letters, vol. 180, no. 2, pp. 147–150, 1994. View at Publisher · View at Google Scholar · View at Scopus